TyRx Pharma, Inc. has entered into a material supply agreement with JFC Technologies for TyRx proprietary polymer production requirements. Under the agreement, JFC's contract manufacturing services will provide TyRx's clinical and commercial supplies of polymer. The two companies have begun manufacturing development activities related to the agreement.

"JFC's capabilities, expertise and capacity in manufacturing degradable polymers makes them an ideal partner for us, and the establishment of this agreement, following on the heels of our previously announced collaboration with C.R. Bard, is a key milestone in our development programs," said Bill Edelman, chief executive officer of TyRx.

"We look forward to supporting TyRx's polymer manufacturing," said Jamie Schleck, president of JFC. "Our collaboration with TyRx exemplifies how JFC partners with its clients from development through commercialization to deliver quality leading-edge polymer products to market."

News from our sister sites